Study Confirms Cannabinoids Occur Naturally In Human Breast Milk according to the latest findings. The human body contains cannabinoid receptors that are specifically designed to process cannabinoids such as tetrahydrocannabinol (THC), one of the primary active components of cannabis. According to the findings of several major scientific studies, human breast milk naturally contains the same cannabinoids found in the cannabis plant, which are vital for proper human development. Cell membranes in the body are naturally equipped with these cannabinoid receptors which, when activated by cannabinoids and various other nutritive substances, protect cells against viruses, harmful bacteria, cancer, and other malignancies. And human breast milk is an abundant source of endocannabinoids, a specific type of neuromodulatory lipid that basically teaches a newborn child how to eat by stimulating the suckling process.
Dr. Melanie Dreher studied women using cannabis during their entire pregnancy and then studied the babies one year after birth. She found that babies of the women who had smoked cannabis daily during their pregnancy socialised more quickly, made eye contact more quickly and were easier to engage.
If it were not for these cannabinoids in breast milk, newborn children would not know how to eat, nor would they necessarily have the desire to eat, which could result in severe malnourishment and even death. Newborn children who are breastfed naturally receive doses of cannabinoids that trigger hunger and promote growth and development. Observations of how babies acts after being fed show they exhibit symptoms of cannabinoid use. As well as the essential function of stimulating an infants appetite, cannabinoids also help to calm and relax the baby. Cannabinoids are not, however, present in baby formula, which makes it far more inferior to breast milk.
Furthermore, a study on the endocannabinoid receptor system that was published in the European Journal of Pharmacology reported, “The medical implications of these novel developments are far reaching and suggest a promising future for cannabinoids in paediatric medicine for conditions including ‘non-organic failure-to-thrive’ and cystic fibrosis.” There are two types of cannabinoid receptors in the body; the CB1 variety which exists in the brain, and the CB2 variety which exists in the immune system and throughout the rest of the body. Each one of these receptors responds to cannabinoids, whether it be from human breast milk in children, or from cannabis.
This essentially means that the human body requires and produces cannabinoids, as these nutritive substances play a critical role in protecting cells against disease, boosting immune function, protecting the brain and nervous system, and relieving pain and disease-causing inflammation.
In a separate study on the endocannabinoids published in the journal Pharmacological Reviews in 2006, researchers from the Laboratory of Physiologic Studies at the National Institute on Alcohol Abuse and Alcoholism uncovered even more about the benefits of cannabinoids. These include their ability to promote proper energy metabolism and appetite regulation, treat metabolic disorders, treat multiple sclerosis, and prevent neurodegeneration, among many other conditions. Cannabinoids, whether naturally produced in the body, or ingested from the cannabis plant itself play a vital function in strengthening the immune system and combatting many cancers and disease